Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Found 5018 publications
Oncology Market Access Europe – Payer and Industry Perspectives US$ 995.00

... experts from the UK, Germany, Italy, France and Spain, FirstWord’s Oncology Market Access Europe – Payer and Industry Perspectives lays out the current – and growing – challenges facing companies in getting drugs to the European market. Filled with compelling insight into the most pressing issues ranging ...

Jul, 2014 75 pages
2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals,... US$ 9,800.00

... be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... growing demand for malignancy assays and the rapid market expansion. US Market Overview Five-year test volume and sales projections ...

Jul, 2014 620 pages
2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and... US$ 6,700.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Spanish Market Overview Five-year test volume and sales ...

Jul, 2014 565 pages
2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and... US$ 6,700.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Spanish Market Overview Five-year test volume and sales ...

Jul, 2014 565 pages
2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and... US$ 8,800.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Japanese Market Overview Five-year test volume and sales ...

Jul, 2014 590 pages
2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and... US$ 6,700.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Italian Market Overview Five-year test volume and sales ...

Jul, 2014 570 pages
2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals,... US$ 6,700.00

... and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. German Market Overview Five-year test volume and sales ...

Jul, 2014 585 pages
2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and... US$ 6,700.00

... and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. French Market Overview Five-year test volume and sales ...

Jul, 2014 585 pages
2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals,... US$ 19,700.00

... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...

Jul, 2014 820 pages
2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals,... US$ 34,500.00

... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...

Jul, 2014 1200 pages
U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape US$ 2,750.00

... players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro ...

Jul, 2014 430 pages
U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape US$ 1,850.00

... players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro ...

Jul, 2014 408 pages
Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape US$ 1,850.00

... players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro ...

Jul, 2014 407 pages
Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape US$ 2,450.00

... players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro ...

Jul, 2014 410 pages
Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape US$ 1,850.00

... players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro ...

Jul, 2014 402 pages
Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape US$ 1,850.00

... players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro ...

Jul, 2014 407 pages
France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape US$ 1,850.00

... players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro ...

Jul, 2014 407 pages
European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape US$ 4,850.00

... players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro ...

Jul, 2014 495 pages
Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape US$ 8,750.00

... players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro ...

Jul, 2014 570 pages
Von Willebrand Disease Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Von Willebrand Disease- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Thyroid Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Thyroid Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Testicular Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Testicular Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Small-Cell Lung Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Small-Cell Lung Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the ...

Jul, 2014
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

... potential and Scope. Understanding the Scope of the Phase III Drugs with nil regulatory filings. Understanding the chemical route of synthesis of approved drugs for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD). Uncovering opportunities in the rapidly growing the US markets.

Jul, 2014
Periodontal Disease Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Periodontal Disease- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
Pancreatic Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Pancreatic Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Metastatic Pancreatic Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Metastatic Pancreatic Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
Metastatic Ovarian Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Metastatic Ovarian Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Metastatic Colorectal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Metastatic Colorectal Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
Metastatic Breast Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Metastatic Breast Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Medullary Thyroid Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Medullary Thyroid Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Lyme Disease Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Lyme Disease- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... File (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Inflammatory Skin Diseases Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Inflammatory Skin Diseases- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Huntington's Disease Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Huntington's Disease- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
Head And Neck Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Head And Neck Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the ...

Jul, 2014
Graves Diseases Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Graves Diseases- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Gaucher's Disease Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Gaucher's Disease- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Gastric Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Gastric Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Esophageal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Esophageal Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

... or altered based on the availability and relevance of data for the indicated disease. Scope A snapshot of the global Market therapeutics scenario for ... the chemical route of synthesis of approved drugs for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Uncovering opportunities in the rapidly ...

Jul, 2014
Diabetic Peripheral Neuropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Diabetic Peripheral Neuropathy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
Diabetic Neuropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Diabetic Neuropathy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
Diabetic Neuropathic Pain Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Diabetic Neuropathic Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Diabetic Nephropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Diabetic Nephropathy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
Diabetic Foot Infection (DFI) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Diabetic Foot Infection (DFI)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish ...

Jul, 2014
Diabetes Insipidus Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

... SUMMARY DelveInsight’s, “ Diabetes Insipidus- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Crohn's Disease Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Crohn's Disease- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Colorectal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Colorectal Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Colon Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Colon Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights ... File (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Chronic Kidney Disease (Chronic Renal Failure) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

... A snapshot of the global Market therapeutics scenario for Chronic Kidney Disease (Chronic Renal Failure). A review of the marketed products under prescription ... key patent expiry details and exclusivity with respect to Chronic Kidney Disease (Chronic Renal Failure). API intelligence over marketed drugs for ...

Jul, 2014
1 2 3 4 5 >
Skip to top